<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/css/bootstrap.min.css" integrity="sha384-9aIt2nRpC12Uk9gS9baDl411NQApFmC26EwAOH8WgZl5MYYxFfc+NcPb1dKGj7Sk" crossorigin="anonymous">

     <style type="text/css">
        body 
        { 
            background-color: #365584;
            font-family: "calibri"; 
            font-size: 18px;
        }
        .nav-background
        {
            background-color: #678BBE;
        }
        .content
        {
            background-color: #B4C0C9; 
            padding:50px;   
            font-size: 28px;  
        }
        .section {
            margin-bottom: 50px;
        }
        .section-header
        {
            background-color: #678BBE; 
            color:white;
            padding-top: 10px; 
            padding-bottom: 10px; 
            margin-bottom: 25px;            
        }
        .inline-div
        {
            display: inline;
        }
        .inline-heading
        {
            margin-left: 20px;
            display: inline; 
        }
    </style>

    <title>OCI Bio Tech Limited</title>
  </head>
  <body>
    <div class="container">
        <!-- Navigation -->
        <nav class="navbar navbar-expand-lg navbar-dark nav-background sticky-top">
            <a class="navbar-brand" href="#">
                <img src="images/logo_small.png">
            </a>
            <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
                <span class="navbar-toggler-icon"></span>
            </button>
            <div class="collapse navbar-collapse" id="navbarNav">
                <ul class="navbar-nav">
                    <li class="nav-item">
                        <a class="nav-link" href="#mission">Mission</a>
                    </li>
                    <li class="nav-item">
                        <a class="nav-link" href="#summary">Summary</a>
                    </li>
                    <li class="nav-item">
                        <a class="nav-link" href="#team">Team</a>
                    </li>
                </ul>
            </div>
        </nav>    
        
        <!-- Header Image-->
        <img id="mission" src="images/banner02.png"  class="img-fluid">

        <!-- Content-->
        <div class="content">
            <!-- OCI Mission Statement -->
            <div class="section">
                <div class="row section-header">
                    <div class="col">
                        <img src="images/logo_small.png">
                        <div class="align-middle inline-div">
                            <h2 class="inline-heading">OCI Mission</h2>                    
                        </div>
                    </div>
                </div>
                <div id="summary">
                        The mission of OCI is to treat widespread and deadly respitory diseases with our unique technology platform.
                </div>
            </div>

            <!-- Summary -->
            <div class="section">
                <div class="row section-header">
                    <div class="col">
                        <img src="images/logo_small.png">
                        <div class="align-middle inline-div">
                            <h2 id="summary" class="inline-heading">Summary</h2>
                        </div>
                    </div>
                </div>
                <div>
                    <p>
                    The OCI ILD Technology inhibits the CYTOKINE STORM the DEADLIEST ACTION of Inflammatory Lung
                    Disease (ILD).  
                    </p>
                    <p>
                    The KEY applications of the OCI ILD Technology are:
                    </p>
                    <ul>
                        <li>Covid</li>
                        <li>SARS</li>
                        <li>MERS</li>
                        <li>Inflammatory Asthma</li>
                        <li>Influenza A</li>
                    </ul>
                    <p>The OCI ILD Technology is NOT antibody dependent, this is critical for the following reasons:</p>
                    <ul>
                        <li>Patients that have been exposed to COVID-19 through vaccination or infection may not develop neutralizing antibodies which provide long-term immunity against the virus.</li>
                        <li>These patients may, however, develop recognizing antibodies, potentially exposing them to a more severe disease course, should they become infected in the future. </li>
                        <li id="team">As the OCI ILD Technology is not antibody dependent, it is key to treating patients who do not develop neutralizing antibodies.</li>
                    </ul>
                </div>
            </div>

            <!-- Team -->
            <div class="section">
                <div class="row section-header">
                    <div class="col">
                        <img src="images/logo_small.png">
                        <div class="align-middle inline-div">
                            <h2 class="inline-heading">OCI Team</h2> 
                        </div>
                    </div>
                </div>
                
                <!-- Roland Franke-->
                <table cellpadding="10">
                    <tr>
                        <td width="112">
                            <img src="images/roland_franke.jpg">
                        </td>
                        <td>
                            <strong>Dr. Roland Franke</strong><br/>
                            <i>Co-Founder, CEO & CSO</i>
                        </td>
                    </tr>
                    <tr>
                        <td colspan="2">
                            <ul>
                                <li>20+ years in the pharma industry. Core expertise - chemistry, molecular biology, business development & executive management.</li>
                                <li>Co-Founder & CEO of NPI, manufacturer of Paclitaxel & Docetaxel API</li>
                                <li>CTO & V.P. of Bus. Dev., Phyton Biotech, manufacturer of Paclitaxel derived from plant cell fermentation. As VP of BD, drove sales increases 40% per year.</li>
                                <li>BSc & MSc Freiburg, PhD & MBA MIT.</li>
                            </ul>
                    </td>
                    </tr>
                </table>
                <hr>

                <!-- Roland Franke-->
                <table cellpadding="10">
                    <tr>
                        <td width="112">
                            <img src="images/rolf_jessberger.jpg">
                        </td>
                        <td>
                            <strong>Prof. Dr. rer. nat. Rolf Jessberger</strong><br/>
                            <i>Co-Founder</i>
                        </td>
                    </tr>
                    <tr>
                        <td colspan="2">
                            <ul>
                                <li>Director of the Institute of Physiological Chemistry, Medical Faculty of Technische Universität Dresden, Germany.                        </li>
                                <li>PhD 1988, University of Cologne, 1989 postdoc with Nobel Laureate PaulBerg at Stanford, California.                        </li>
                                <li>Independent group leader 1992 at the Basel Institute for Immunology,Switzerland.                        </li>
                                <li>2000 to 2008 faculty at Mount Sinai School of Medicine, NY, 2005 fullProfessor in Dresden; Dean of Research 2012-2015.                        </li>
                            </ul>
                    </td>
                    </tr>
                </table>
                <hr>                

                <!-- Jaroslav Frantisek-->
                <table cellpadding="10">
                    <tr>
                        <td width="112">
                            <img src="images/jaroslav_fratisek.jpg">
                        </td>
                        <td>
                            <strong>Dr. Jaroslav Frantisek</strong><br/>
                            <i>Head Of Chemistry, Brno                            </i>
                        </td>
                    </tr>
                    <tr>
                        <td colspan="2">
                            <ul>
                                <li>24 years in pharma industry. Core expertise analytical chemistry, method development, validation, focus on separation techniques and mass spectrometry.</li>
                                <li>Co-founder and managing director of Ratiochem CRO, specialized in synthetic route design and development.</li>
                                <li>Dipl. Ing. and post-graduate study University Pardubice, Czech Republic.</li>
                            </ul>
                    </td>
                    </tr>
                </table>
                <hr>                

                <!-- Austin McDonald -->
                <table cellpadding="10">
                    <tr>
                        <td width="112">
                            <img src="images/austin_mcdonald.jpg">
                        </td>
                        <td>
                            <strong>Austin McDonald</strong><br/>
                            <i>COO &amp; Infrastructure Implementation</i>
                        </td>
                    </tr>
                    <tr>
                        <td colspan="2">
                            <ul>
                                <li>30+ years in the pharma industry. Core expertise - facility, process & supply chain implementation, product realization, compliance and executive management.</li>
                                <li>Former CEO of OncoGenerix, led the company through facilities construction, QMS implementation and EU approval.</li>
                                <li>Former Adjunct Professor, Stevens Institute of Technology MSc Program.</li>
                                <li>25+ years of project management and process engineering experience leading EPCMV for numerous GMP infrastructure projects.</li>
                                <li>Strategic planning, resourcing, quality management systems and international regulatory compliance.</li>
                                <li>SME in isolator systems, sterilization, sterile processing, automated inspection & packaging systems and the handling of complex materials including, cytotoxic / carcinogenic substances, biological hazards and radioactive pharmaceuticals</li>
                            </ul>
                    </td>
                    </tr>
                </table>
                <hr>                

                <!-- Austin McDonald -->
                <table cellpadding="10">
                    <tr>
                        <td width="112">
                            <img src="images/renee_pacilio.png">
                        </td>
                        <td>
                            <strong>Renée Pacilio</strong><br/>
                            <i>Infrastructure Master Planning</i>
                        </td>
                    </tr>
                    <tr>
                        <td colspan="2">
                            <ul>
                                <li>25+ years in the pharma industry with focus on architectural design, project management, and construction management with special emphasis on on GMP infrastructure projects including OSD, biotech and sterile manufacturing facilities. </li>
                                <li>Core specialist capabilities include site / facility master planning, facility concept design development, facility detailed design, subcontract preparation, cost estimating and contracts administration. </li>
                                <li>B. Architecture, NJIT. AIA.</li>
                            </ul>
                    </td>
                    </tr>
                </table>
                <hr>                
            </div>
        </div>

    </div>
    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.min.js" integrity="sha384-OgVRvuATP1z7JjHLkuOU7Xw704+h835Lr+6QL9UvYjZE3Ipu6Tp75j7Bh/kR0JKI" crossorigin="anonymous"></script>
  </body>
</html>